Compute Health Acquisition Corp. received a nyse deficiency notice notice regarding board independence (rules 303A.01).
Exchange
nyse
Notice
deficiency notice
Deficiency
board independence
Rules
303A.01
Exact text from the filing
January 31, 2023, the Company notified the New York Stock Exchange (the “NYSE”) that, after giving effect to Dr. Alswailem’s resignation, the Company no longer had a majority of independent directors as required by Section 303A.01 of the NYSE Listed Company Manual.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.